Surgical Complications in Patients with (borderline) Resectable Pancreatic Cancer after Neoadjuvant Therapy in the PREOPANC-2 Randomized Controlled Trial
In the PREOPANC-2 randomized trial, the risk of major surgical complications after pancreatic resection following neoadjuvant FOLFIRINOX or neoadjuvant gemcitabine-based chemoradiotherapy was similar with an overall low 90-day mortality.
Authors
- Roeland F. de Wilde (ORCID: https://orcid.org/0009-0003-0444-8697)
- Marion van der Kolk (ORCID: https://orcid.org/0000-0003-0294-0496)
- Casper H.J. van Eijck (ORCID: https://orcid.org/0000-0002-9511-2157)
- Hjalmar C. van Santvoort (ORCID: https://orcid.org/0009-0007-1218-2883)
- Marc G. Besselink (ORCID: https://orcid.org/0000-0003-2650-9350)
- Stefan A.W. Bouwense (ORCID: https://orcid.org/0000-0002-7600-9429)
- Mike S.L. Liem (ORCID: https://orcid.org/0000-0001-8665-1506)
- J. Sven D. Mieog (ORCID: https://orcid.org/0000-0002-3649-8504)
- Bas Groot Koerkamp (ORCID: https://orcid.org/0000-0003-1917-6973)
- Geertjan van Tienhoven (ORCID: https://orcid.org/0000-0002-2516-2263)
- Olivier R. Busch (ORCID: https://orcid.org/0000-0001-9605-6831)
- Tom M. Karsten
- Gijs A. Patijn
- Thomas F. Stoop (ORCID: https://orcid.org/0000-0003-3328-4516)
- Bert A. Bonsing (ORCID: https://orcid.org/0000-0003-4513-5737)
- Quisette P. Janssen (ORCID: https://orcid.org/0000-0002-9353-8293)
- K. Bosscha
- Geert Kazemier (ORCID: https://orcid.org/0000-0002-9811-3497)
- Babs M. Zonderhuis (ORCID: https://orcid.org/0000-0003-1383-7021)
- Ignace H. J. T. de Hingh (ORCID: https://orcid.org/0000-0003-3491-4268)
- Erwin van her Harst
- Marjolein Y.V. Homs (ORCID: https://orcid.org/0000-0001-9828-2541)
- Esther N. Dekker (ORCID: https://orcid.org/0000-0002-3040-6736)
- Jacob L. van Dam (ORCID: https://orcid.org/0000-0002-6947-9035)
- Rutger T. Theijse
- Johanna W. Wilmink
- Peter‐Paul L. O. Coene
- Vincent B. Nieuwenhuijs (ORCID: https://orcid.org/0000-0001-9311-8208)
- Jennifer M. J. Schreinemakers
- Fennie Wit (ORCID: https://orcid.org/0000-0002-1550-2607)
Institutions
- Radboud University Nijmegen (NL)
- Marathon Oil (United States) (US)
- Leiden University Medical Center (NL)
- Catharina Ziekenhuis (NL)
- Medisch Spectrum Twente (NL)
- Medisch Centrum Leeuwarden (NL)
- Radboud University Medical Center (NL)
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Ta Solutions (China) (CN)
- Marienkrankenhaus Kassel (DE)
- St. Antonius Ziekenhuis (NL)
- OLVG (NL)
- Amphia Ziekenhuis (NL)
- Amsterdam Neuroscience (NL)
- Maasstad Ziekenhuis (NL)
- Directorate-General for Interpretation (BE)
- Emergent BioSolutions (Canada) (CA)
- Isala (NL)
- Erasmus MC Cancer Institute (NL)
- Amsterdam University Medical Centers (NL)
- Real-Time Innovations (United States) (US)
- Jeroen Bosch Ziekenhuis (NL)
- Cancer Center Amsterdam (NL)
- University of Amsterdam (NL)
Publication Details
- Journal
- Annals of Surgery
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1097/sla.0000000000006910
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- ZonMw